{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:34:54Z","timestamp":1788914094125,"version":"build-2803163510"},"reference-count":48,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T00:00:00Z","timestamp":1096588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2004,10]]},"DOI":"10.1016\/j.biopsych.2004.07.006","type":"journal-article","created":{"date-parts":[[2004,9,24]],"date-time":"2004-09-24T17:01:27Z","timestamp":1096045287000},"page":"503-509","source":"Crossref","is-referenced-by-count":75,"title":["Tryptophan depletion reverses the therapeutic effect of selective serotonin reuptake inhibitors in social anxiety disorder"],"prefix":"10.1016","volume":"56","author":[{"given":"Spilios V.","family":"Argyropoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean D.","family":"Hood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariona","family":"Adrover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline J.","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann S.","family":"Rich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon R.","family":"Nash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil C.","family":"Rich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry J.","family":"Witchel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Nutt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2004.07.006_bib1","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1600-0447.1999.tb10845.x","article-title":"Paroxetine in social anxiety disorder: A randomized placebo-controlled study","volume":"100","author":"Allgulander","year":"1999","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.biopsych.2004.07.006_bib2","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1034\/j.1600-0447.2001.00320.x","article-title":"A prospective study of 86 new patients with social anxiety disorder","volume":"103","author":"Allgulander","year":"2001","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.biopsych.2004.07.006_bib3","series-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"1994"},{"key":"10.1016\/j.biopsych.2004.07.006_bib4","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0193-953X(05)70259-8","article-title":"Brain function in social anxiety disorder","volume":"24","author":"Argyropoulos","year":"2001","journal-title":"Psychiatr Clin North Am"},{"key":"10.1016\/j.biopsych.2004.07.006_bib5","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1192\/bjp.175.2.120","article-title":"Paroxetine in social phobia\/social anxiety disorder","volume":"175","author":"Baldwin","year":"1999","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.biopsych.2004.07.006_bib6","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1001\/archpsyc.1994.03950040053007","article-title":"Tryptophan depletion in patients with obsessive-compulsive disorder who respond to serotonin reuptake inhibitors","volume":"51","author":"Barr","year":"1994","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2004.07.006_bib7","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0006-3223(96)00224-7","article-title":"Effects of fluoxetine administration on mood response to tryptophan depletion in healthy subjects","volume":"41","author":"Barr","year":"1997","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2004.07.006_bib8","series-title":"Beck Depression Inventory Manual","author":"Beck","year":"1987"},{"issue":"suppl 17","key":"10.1016\/j.biopsych.2004.07.006_bib9","first-page":"27","article-title":"Social anxiety disorder: Etiology and early clinical presentation","volume":"59","author":"Beidel","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.biopsych.2004.07.006_bib10","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1192\/bjp.178.5.399","article-title":"Tryptophan depletion and its implications for psychiatry","volume":"178","author":"Bell","year":"2001","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.biopsych.2004.07.006_bib11","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/026988110201600116","article-title":"Does 5-HT restrain panic?","volume":"16","author":"Bell","year":"2002","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.biopsych.2004.07.006_bib12","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1192\/bjp.179.1.23","article-title":"Randomised controlled general practice trial of sertraline, exposure therapy and combined treatment in generalised social phobia","volume":"179","author":"Blomhoff","year":"2001","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.biopsych.2004.07.006_bib13","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.2044-8341.1974.tb02285.x","article-title":"The use of analogue scales in rating subjective feelings","volume":"47","author":"Bond","year":"1974","journal-title":"Br J Med Psychol"},{"key":"10.1016\/j.biopsych.2004.07.006_bib14","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0893-133X(97)00198-X","article-title":"Tryptophan depletion during continuous CSF sampling in healthy human subjects","volume":"19","author":"Carpenter","year":"1998","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2004.07.006_bib15","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1192\/bjp.176.4.379","article-title":"Psychometric properties of the Social Phobia Inventory (SPIN)","volume":"176","author":"Connor","year":"2000","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.biopsych.2004.07.006_bib16","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1037\/0022-006X.56.5.734","article-title":"Emotional imagery and the differential diagnosis of anxiety","volume":"56","author":"Cook","year":"1988","journal-title":"J Consult Clin Psychol"},{"key":"10.1016\/j.biopsych.2004.07.006_bib17","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S0006-3223(99)00014-1","article-title":"Tryptophan-depletion challenge in depressed patients treated with desipramine or fluoxetine: Implications for the role of serotonin in the mechanism of antidepressant action","volume":"46","author":"Delgado","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2004.07.006_bib18","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1017\/S0033291701004056","article-title":"The Liebowitz Social Anxiety Scale: A comparison of the psychometric properties of self-report and clinician-administered formats","volume":"31","author":"Fresco","year":"2001","journal-title":"Psychol Med"},{"key":"10.1016\/j.biopsych.2004.07.006_bib19","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0091-3057(95)02135-3","article-title":"Role of 5-HT in stress, anxiety, and depression","volume":"54","author":"Graeff","year":"1996","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.biopsych.2004.07.006_bib20","series-title":"ECDEU Assessment Manual for Psychopharmacology: Publication ADM 76\u2013338","author":"Guy","year":"1976"},{"key":"10.1016\/j.biopsych.2004.07.006_bib21","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1176\/ajp.152.9.1368","article-title":"Sertraline for social phobia: A double-blind, placebo-controlled crossover study","volume":"152","author":"Katzelnick","year":"1995","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2004.07.006_bib22","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1001\/archpsyc.1994.03950010008002","article-title":"Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States","volume":"51","author":"Kessler","year":"1994","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2004.07.006_bib23","doi-asserted-by":"crossref","first-page":"785","DOI":"10.4088\/JCP.v64n0708","article-title":"Efficacy of sertraline in severe generalized social anxiety disorder: Results of a double-blind, placebo-controlled study","volume":"64","author":"Liebowitz","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.biopsych.2004.07.006_bib24","doi-asserted-by":"crossref","first-page":"66","DOI":"10.4088\/JCP.v63n0113","article-title":"A randomized, double-blind, fixed-dose comparison of paroxetine and placebo in the treatment of generalized social anxiety disorder","volume":"63","author":"Liebowitz","year":"2002","journal-title":"J Clin Psychiatry"},{"issue":"part II","key":"10.1016\/j.biopsych.2004.07.006_bib25","first-page":"S301","article-title":"Neural correlates of anxiety provocation in social phobia","volume":"5","author":"Malizia","year":"1997","journal-title":"Neuroimage"},{"key":"10.1016\/j.biopsych.2004.07.006_bib26","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1037\/0021-843X.102.2.212","article-title":"Emotional imagery in simple and social phobia: Fear versus anxiety","volume":"102","author":"McNeil","year":"1993","journal-title":"J Abnorm Psychol"},{"key":"10.1016\/j.biopsych.2004.07.006_bib27","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0024-3205(89)90497-9","article-title":"Dose-response decrease in plasma tryptophan and in brain tryptophan and serotonin after tryptophan-free amino acid mixtures in rats","volume":"44","author":"Moja","year":"1989","journal-title":"Life Sci"},{"key":"10.1016\/j.biopsych.2004.07.006_bib28","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/sj.mp.4000962","article-title":"Association between a serotonin transporter promoter region polymorphism and mood response during tryptophan depletion","volume":"7","author":"Moreno","year":"2002","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2004.07.006_bib29","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/(SICI)1520-6394(1996)4:4<153::AID-DA1>3.0.CO;2-G","article-title":"Molecular and cellular mechanisms of antidepressant drugs","volume":"4","author":"Owens","year":"1996","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.biopsych.2004.07.006_bib30","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1177\/026988119701100416","article-title":"Rapid depletion of plasma tryptophan: A review of studies and experimental methodology","volume":"11","author":"Reilly","year":"1997","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.biopsych.2004.07.006_bib31","first-page":"322","article-title":"Functional impairment in social phobia","volume":"55","author":"Schneier","year":"1994","journal-title":"J Clin Psychiatry"},{"issue":"suppl 20","key":"10.1016\/j.biopsych.2004.07.006_bib32","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.biopsych.2004.07.006_bib33","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0140-6736(96)07044-4","article-title":"Relapse of depression after rapid depletion of tryptophan","volume":"349","author":"Smith","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.biopsych.2004.07.006_bib34","series-title":"Manual for the State-Trait Anxiety Inventory","author":"Spielberger","year":"1983"},{"key":"10.1016\/j.biopsych.2004.07.006_bib35","first-page":"402","article-title":"A double-blind placebo-controlled trial of paroxetine in the management of social phobia (social anxiety disorder) in South Africa","volume":"89","author":"Stein","year":"1999","journal-title":"S Afr Med J"},{"key":"10.1016\/j.biopsych.2004.07.006_bib36","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1001\/archpsyc.59.12.1111","article-title":"Efficacy of paroxetine for relapse prevention in social anxiety disorder: A 24-week study","volume":"59","author":"Stein","year":"2002","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2004.07.006_bib37","first-page":"756","article-title":"Fluvoxamine treatment of social phobia (social anxiety disorder): A double-blind, placebo-controlled study","volume":"156","author":"Stein","year":"1999","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2004.07.006_bib38","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1001\/jama.280.8.708","article-title":"Paroxetine treatment of generalized social phobia (social anxiety disorder): A randomized controlled trial","volume":"280","author":"Stein","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.biopsych.2004.07.006_bib39","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1176\/appi.ajp.158.8.1220","article-title":"Cerebral blood flow in subjects with social phobia during stressful speaking tasks: A PET study","volume":"158","author":"Tillfors","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2004.07.006_bib40","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1176\/appi.ajp.158.2.275","article-title":"Sertraline treatment of generalized social phobia: A 20-week, double-blind, placebo-controlled study","volume":"158","author":"Van Ameringen","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2004.07.006_bib41","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/BF02244762","article-title":"Psychopharmacological treatment of social phobia: A double blind placebo controlled study with fluvoxamine","volume":"115","author":"van Vliet","year":"1994","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.biopsych.2004.07.006_bib42","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/00004714-200012000-00009","article-title":"Prevention of relapse in generalized social phobia: Results of a 24-week study in responders to 20 weeks of sertraline treatment","volume":"20","author":"Walker","year":"2000","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.biopsych.2004.07.006_bib43","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1037\/h0027806","article-title":"Measurement of social-evaluative anxiety","volume":"33","author":"Watson","year":"1969","journal-title":"J Consult Clin Psychol"},{"key":"10.1016\/j.biopsych.2004.07.006_bib44","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0006-3223(00)01123-9","article-title":"No evidence for in vivo regulation of midbrain serotonin transporter availability by serotonin transporter promoter gene polymorphism","volume":"50","author":"Willeit","year":"2001","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2004.07.006_bib45","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1046\/j.1471-4159.1999.721641.x","article-title":"Effects of acute tryptophan depletion on plasma and cerebrospinal fluid tryptophan and 5-hydroxyindoleacetic acid in normal volunteers","volume":"72","author":"Williams","year":"1999","journal-title":"J Neurochem"},{"key":"10.1016\/j.biopsych.2004.07.006_bib46","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0193-953X(05)70254-9","article-title":"Epidemiology, patterns of comorbidity, and associated disabilities of social phobia","volume":"24","author":"Wittchen","year":"2001","journal-title":"Psychiatr Clin North Am"},{"key":"10.1016\/j.biopsych.2004.07.006_bib47","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1017\/S0033291798008174","article-title":"Social fears and social phobia in a community sample of adolescents and young adults: Prevalence, risk factors and co-morbidity","volume":"29","author":"Wittchen","year":"1999","journal-title":"Psychol Med"},{"key":"10.1016\/j.biopsych.2004.07.006_bib48","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1600-0447.2000.tb10947.x","article-title":"Anxiety disorders: A review of tricyclic antidepressants and selective serotonin reuptake inhibitors","volume":"403","author":"Zohar","year":"2000","journal-title":"Acta Psychiatr Scand Suppl"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322304007681?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322304007681?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,3]],"date-time":"2019-02-03T13:21:25Z","timestamp":1549200085000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322304007681"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10]]},"references-count":48,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["S0006322304007681"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2004.07.006","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2004,10]]}}}